English | Español

Technology/Innovation
+ Technology/Innovation
Press release submission | Apr 10, 2019

TREMOTYX BIOMEDICAL LAB: Debuts Plant Stem Cell-Based Eczema Treatment in the U.S.
+ Technology/Innovation
Press release submission | Apr 4, 2019

VARIAN MEDICAL SYSTEM: Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
+ Technology/Innovation
Press release submission | Mar 30, 2019

BIOLINERX LTD.: Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients
+ Technology/Innovation
Press release submission | Mar 20, 2019

INNOVENT BIOLOGICS, INC. : Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
+ Technology/Innovation
Press release submission | Mar 15, 2019

AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
+ Technology/Innovation
Karen Kidd | Mar 11, 2019

New technologies can treat anxiety, depression through at-home brain stimulation
+ Technology/Innovation
Press release submission | Mar 7, 2019

ALLERGAN, PLC: FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
+ Technology/Innovation
Press release submission | Feb 27, 2019

INNOVENT BIOLOGICS, INC.: First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes